Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
6 March 2017
E-001508-17
Question for written answer
to the Commission
Rule 130
Daniel Buda (PPE)

 Subject:  Shortage of cancer drugs
 Answer(s) 

In Romania, there are over 850 000 persons suffering from cancer; 130 patients die daily because of this disease. Out of the total number of persons suffering from cancer, only 100 000 are getting treatment for this disease.

At present, a new shortage of cancer drugs has been identified in Romania. Seven types of treatments for children and 16 for adults are no longer present on the pharmaceutical market. The causes of this situation arise from the problems related to parallel export.

This practice of parallel export has generated a shortage in the stocks of medicines for the domestic market.

Are there any tools which the Commission has at its disposal to support the continuation of these treatments for persons suffering from cancer?

Original language of question: RO 
Last updated: 27 March 2017Legal notice